Evidence map›Paper›PMID 39144828›Full record

ArticleFrontiers in oncology2024

Prospective comparison of

Feifan Xiang, Yue Zhang, Xiaoqi Tan, Yuanzhuo Yan, Huipan Liu, Wenzhe Ma, Yue Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The performance ofScientific reports · 2026
    Article
  2. Comparison ofScientific reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Feifan Xiang *The State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, Macao SAR, China.
Yue Zhang *Department of Orthopedic, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Xiaoqi TanDepartment of Dermatology, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Yuanzhuo YanDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Huipan LiuDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Wenzhe MaThe State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, Macao SAR, China.
Yue ChenDepartment of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Materials and methods: In this prospective study, 45 women with BC underwent imaging via Results: The 45 women were aged 53.5 ± 11.0 years. The bone metastases detection rate with Conclusions: Clinical trial registration: https://www.chictr.org.cn/showproj.html?proj=170163, identifier ChiCTR2200064487.

Indexed as

bone metastasesbreast cancercomputed tomographypositron emission tomographywhole-body bone scan

Identifiers

PMID39144828
PMCPMC11323743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.